糖蛋白
多克隆抗体
牛冠状病毒
生物
糖基化
单克隆抗体
病毒学
抗原性
冠状病毒
分子生物学
生物化学
抗体
2019年冠状病毒病(COVID-19)
遗传学
传染病(医学专业)
病理
医学
疾病
作者
Dirk Deregt,Marta Sabara,Lorne A. Babiuk
标识
DOI:10.1099/0022-1317-68-11-2863
摘要
Summary The Quebec isolate of bovine coronavirus (BCV) was found to contain four unique major structural proteins. These proteins consisted of the peplomeric protein (gp190/E2, gp100/E2), the nucleocapsid protein (p53/N) and its apparent trimer (p160/N), a family of small matrix glycoproteins (gp26/El, gp25/El and p23/El) and the putative haemagglutinin (gpl24/E3). Pulse-chase experiments utilizing polyclonal antiserum and monoclonal antibodies indicated that the unique BCV E3 protein had as its primary precursor an A-linked glycoprotein with an M r of 59000 (gp59) which underwent rapid dimerization by disulphide bond formation to yield gp118. Further glycosylation of gp118 produced gp124/E3 which incorporated fucose. Thus gp124/E3 was probably a homodimer. The processing of the E2 and E1 proteins of BCV was similar to that shown previously for mouse hepatitis virus. A large AM inked precursor glycoprotein, gpl70, underwent further glycosylation to yield gp190/E2 before subsequent proteolytic cleavage to yield gp100/E2. The glycosylated El (gp26, gp25) proteins arose as a result of O-linked glycosylation of p23/El as indicated by the resistance of these species to tunicamycin.
科研通智能强力驱动
Strongly Powered by AbleSci AI